Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -58.42%417.59M | -45.07%3.13B | -69.88%1B | 1.78%5.7B | 37.93%3.33B | -51.06%5.6B | -74.67%2.42B | -27.26%11.45B | 9.56%9.54B | 8.17%15.74B |
| Operating income | -58.42%417.59M | -45.07%3.13B | -69.88%1B | 1.78%5.7B | 37.93%3.33B | -51.06%5.6B | -74.67%2.42B | -27.26%11.45B | 9.56%9.54B | 8.17%15.74B |
| Cost of sales | 67.62%-367.43M | 64.63%-3.59B | 63.95%-1.13B | -51.04%-10.15B | -36.19%-3.15B | 37.76%-6.72B | 68.48%-2.31B | 9.71%-10.8B | -11.28%-7.33B | -10.25%-11.96B |
| Operating expenses | 67.62%-367.43M | 64.63%-3.59B | 63.95%-1.13B | -51.04%-10.15B | -36.19%-3.15B | 37.76%-6.72B | 68.48%-2.31B | 9.71%-10.8B | -11.28%-7.33B | -10.25%-11.96B |
| Gross profit | 138.49%50.15M | 89.75%-455.57M | -169.64%-130.31M | -298.62%-4.44B | 75.80%187.13M | -270.44%-1.11B | -95.19%106.44M | -82.72%654.12M | 4.23%2.21B | 2.08%3.78B |
| Selling expenses | 13.94%-33.84M | 61.89%-118.73M | 72.00%-39.32M | 16.49%-311.59M | 28.16%-140.42M | 43.93%-373.12M | 36.88%-195.46M | -14.12%-665.43M | -49.89%-309.67M | -9.99%-583.09M |
| Administrative expenses | 26.96%-60.55M | 28.19%-184.08M | 7.67%-82.9M | 39.61%-256.35M | 60.77%-89.79M | 36.71%-424.52M | 43.15%-228.88M | 5.89%-670.8M | -49.77%-402.63M | -4.60%-712.82M |
| Revaluation surplus | ---- | -279.58%-318.31M | ---- | -220.68%-83.86M | ---- | -145.59%-26.15M | ---- | -75.76%57.36M | 10.64%127.91M | -33.80%236.64M |
| -Changes in the fair value of investment property | ---- | -279.58%-318.31M | ---- | -220.68%-83.86M | ---- | 39.91%-26.15M | ---- | -152.55%-43.52M | -32.91%31.99M | 31.33%82.81M |
| -Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -34.42%100.88M | 41.21%95.92M | -47.75%153.83M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | 6.93%-191.42M | 1.51%-404M | -23.47%-205.67M | 2.35%-410.18M |
| Special items of operating profit | 99.99%-159K | 49.72%-3.79B | -290.77%-2.46B | -250.55%-7.54B | 28.17%-629.41M | -334.13%-2.15B | -555.52%-876.22M | -204.31%-495.77M | 228.82%192.35M | 76.35%475.3M |
| Operating profit | 98.36%-44.4M | 61.47%-4.87B | -303.29%-2.71B | -208.99%-12.64B | 51.46%-672.49M | -168.34%-4.09B | -185.89%-1.39B | -154.63%-1.52B | 11.61%1.61B | 3.25%2.79B |
| Financing cost | -1.37%-1.14B | 21.68%-2.23B | -373.99%-1.13B | -659.38%-2.85B | ---237.68M | ---375.69M | ---- | ---- | ---- | ---- |
| Share of profits of associates | 39.15%-387K | 48.25%-769K | 77.82%-636K | 30.53%-1.49M | -189.60%-2.87M | 45.00%-2.14M | 5.80%-990K | -1,283.99%-3.89M | -371.30%-1.05M | 78.01%-281K |
| Share of profit from joint venture company | 194.56%28.63M | -66.60%-56.94M | 58.74%-30.27M | 82.74%-34.18M | -258.76%-73.38M | -481.55%-198.02M | 359.43%46.22M | -144.42%-34.05M | 1.17%-17.82M | 346.70%76.66M |
| Earning before tax | 70.07%-1.16B | 53.88%-7.16B | -292.29%-3.87B | -232.76%-15.53B | 26.40%-986.42M | -198.68%-4.67B | -184.07%-1.34B | -154.50%-1.56B | 11.72%1.59B | 7.36%2.87B |
| Tax | 99.57%-776K | -10.85%-397.41M | -28.62%-182.12M | -50.53%-358.51M | 1.42%-141.59M | 68.96%-238.17M | 84.35%-143.63M | 56.15%-767.29M | -5.41%-917.8M | -8.29%-1.75B |
| After-tax profit from continuing operations | 71.39%-1.16B | 52.42%-7.56B | -259.19%-4.05B | -223.91%-15.89B | 23.99%-1.13B | -110.54%-4.9B | -319.34%-1.48B | -308.58%-2.33B | 21.59%676.54M | 5.93%1.12B |
| Earning after tax | 71.39%-1.16B | 52.42%-7.56B | -259.19%-4.05B | -223.91%-15.89B | 23.99%-1.13B | -110.54%-4.9B | -319.34%-1.48B | -308.58%-2.33B | 21.59%676.54M | 5.93%1.12B |
| Minority profit | 80.21%-51.08M | 93.58%-101.06M | -105.63%-258.15M | -249.05%-1.58B | 48.83%-125.54M | -64.02%-451.25M | -207.18%-245.36M | -172.79%-275.12M | 44.63%228.93M | 16.74%377.98M |
| Profit attributable to shareholders | 70.79%-1.11B | 47.89%-7.46B | -278.42%-3.79B | -221.37%-14.31B | 19.06%-1B | -116.76%-4.45B | -376.71%-1.24B | -378.03%-2.05B | 12.43%447.61M | 1.14%739M |
| Basic earnings per share | 70.82%-0.396 | 47.88%-2.669 | -277.99%-1.357 | -221.27%-5.121 | 18.96%-0.359 | -116.87%-1.594 | -376.88%-0.443 | -378.41%-0.735 | 12.68%0.16 | 0.76%0.264 |
| Diluted earnings per share | 70.82%-0.396 | 47.88%-2.669 | -277.99%-1.357 | -221.27%-5.121 | 18.96%-0.359 | -116.87%-1.594 | -376.88%-0.443 | -378.41%-0.735 | 12.68%0.16 | 1.15%0.264 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | -- | -- | -- | -- | -- | -- | -- | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.